- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 213/44 - Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
Patent holdings for IPC class C07D 213/44
Total number of patents in this class: 32
10-year publication summary
|
1
|
4
|
4
|
3
|
1
|
0
|
3
|
3
|
2
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Fortephest Ltd. | 12 |
3 |
| Centre National de La Recherche Scientifique | 11023 |
2 |
| The General Hospital Corporation | 4870 |
2 |
| University of Florida Research Foundation, Inc. | 4174 |
2 |
| ChemoCentryx, Inc. | 361 |
2 |
| Unicycive Therapeutics, Inc. | 28 |
2 |
| Novartis AG | 10262 |
1 |
| F. Hoffmann-La Roche AG | 7837 |
1 |
| Hoffmann-La Roche Inc. | 3793 |
1 |
| Merck Sharp & Dohme Corp. | 2183 |
1 |
| Canon Inc. | 43817 |
1 |
| Bayer Intellectual Property GmbH | 2364 |
1 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 775 |
1 |
| Harbin Medisan Pharmaceutical Co., Ltd. | 17 |
1 |
| InterMune, Inc. | 47 |
1 |
| Musc Foundation for Research Development | 368 |
1 |
| Neuralstem, Inc. | 19 |
1 |
| Raqualia Pharma Inc. | 123 |
1 |
| University of Arizona | 14 |
1 |
| Inflazome Limited | 84 |
1 |
| Other owners | 5 |